NCI MAMMOGRAPHY SCREENING RECOMMENDATIONS SHOULD BE REVISED
This article was originally published in The Gray Sheet
Executive Summary
NCI MAMMOGRAPHY SCREENING RECOMMENDATIONS SHOULD BE REVISED to reflect the possibility of benefit from screening women under age 50, the House Committee on Government Operations asserts in a report approved Oct. 7 by the committee. The report, entitled "Misused Science: The National Cancer Institute's Elimination of Mammography Guidelines for Women in their Forties," criticizes NCI's decision to eliminate screening guidelines for women aged 40-49 and maintains that NCI has "created confusion about the importance of mammography screening."
You may also be interested in...
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.